USD 23.07 Billion by 2032, Growing at a CAGR of 7.60% From 2024-2032. The coronary stent market includes the creation, sale, and use of compact tubes which expand to open occluded or constricted coronary arteries. These devices are placed in a patient to address narrowing of an artery, commonly following an angioplasty where the blood vessel is enlarged. Market has different kinds of stents, including bare-metal stents, drug eluting stents and bioresorbable stents, that are useful to address medical requirements and foster patient clinical conditions. Such products are applied in the treatment of coronary artery disease (CAD), one of the leading causes of death globally, and are central to virtually all interventional cardiology procedures across the world.